$AIM
AIM ImmunoTech Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
$0.207
▼-4.51%-$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAIM ImmunoTech Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Why is AIM down today? It is at $0.207 (-4.51%), and our scanner flagged it 151 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AIM spikes, and full due diligence on AIM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AIM 151 times in the last 30 days. Create a free account to track $AIM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AIM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AIM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Equels Thomas K Officer | Bought (open market) | +24K 0.06% of company | added 23% | 127K | $5K at $0.210 | Sep 17, 26 |
Equels Thomas K Officer | Bought (open market) | +11K 0.03% of company | added 12% | 103K | $2K at $0.210 | Sep 16, 26 |
Equels Thomas K Officer | Bought (open market) | +22K 0.06% of company | added 32% | 92K | $5K at $0.220 | Sep 15, 26 |
Equels Thomas K Officer | Bought (open market) | +6K 0.02% of company | added 9.2% | 70K | $1K at $0.220 | Sep 14, 26 |
Chemerow David I. Director | Acquired (grant/award) | +25K 0.07% of company | added 100% | 28K | n/a | Mar 12, 26 |
Equels Thomas K Officer | Acquired (grant/award) | +25K 0.07% of company | added 64% | 64K | n/a | Mar 12, 26 |
Chemerow David I. Director | Acquired (grant/award) | +3K | added 100% | 3K | $3K at $1.23 | Feb 5, 26 |
Equels Thomas K Officer | Bought (open market) | +107 | added 0.3% | 39K | $824 at $7.70 | Jun 13, 25 |
Equels Thomas K Officer | Bought (open market) | +103 | added 0.3% | 39K | $896 at $8.70 | Jun 12, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on AIM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AIM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AIM last traded at $0.207, down 4.51% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The AIM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AIM 151 times in the last 30 days.
AIM (AIM ImmunoTech Inc.) trades on XASE, with a market cap of about $8M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AIM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AIM discussion
Sign in to ask a question or join the discussion.